✦ LIBER ✦

Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients

✍ Scribed by M. Buti; I. Elefsiniotis; R. Jardi; V. Vargas; F. Rodriguez-Frias; M. Schapper; S. Bonovas; R. Esteban

Book ID: 116651374
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 227 KB
Volume: 47
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2007.04.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overlap lamivudine treatment in patients

Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants

✍ C.-J. Liu; J.-H. Kao; P.-J. Chen; T.-C. Chen; F.-Y. Lin; M.-Y. Lai; D.-S. Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Extended treatment with lamivudine and a

Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

✍ Robert P. Perrillo; Hie-Won Hann; Eugene Schiff; David Mutimer; Bernard Willems; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 309 KB

515 Non-response and resistance to adefo

515 Non-response and resistance to adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

✍ A. Valdes; M. Buti; R. Jardi; E. Rodriguez-Frias; M. Schaner; R. Esteban; J. Gua 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 234 KB

[495] VIROLOGIC RESPONSE AT TREATMENT MO

[495] VIROLOGIC RESPONSE AT TREATMENT MONTH 12 MAY PREDICT SUSTAINED ANTIVIRAL EFFICACY IN ADEFOVIR TREATED LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B

✍ W.S. Han; J.E. Yeon; Y.H. Kim; S.N. Oh; Y.S. Seo; H.J. Yim; W.H. Choe; S.Y. Kwon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Efficacy of entecavir in patients with c

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone

✍ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/

539 Genotypic and phenotypic resistance

539 Genotypic and phenotypic resistance profiles to adefovir dipivoxil in lamivudine-resistant chronic hepatitis B treated with ADV

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 250 KB